Spectroscopic studies of the oxidation of ferric CYP153A6 by peracids: Insights into P450 higher oxidation states

• Published in: Archives of biochemistry and biophysics 2010-01, Vol.493 (2), p.184-191
• Main Authors: Spolitak, Tatyana, Funhoff, Enrico G., Ballou, David P.
• Format: Article
• Language: English
• Subjects: Alkane hydroxylation; Chlorobenzoates - chemistry; Chlorobenzoates - pharmacology; Cpd I; Cpd II; Cyp153A6; Cytochrome P-450 Enzyme System - chemistry; Cytochrome P-450 Enzyme System - genetics; Cytochrome P-450 Enzyme System - metabolism; Cytochrome P450; Ferric Compounds - chemistry; Ferric Compounds - metabolism; Ferryl intermediates; Hydrogen-Ion Concentration; Mycobacterium - enzymology; Mycobacterium - genetics; Oxidants - chemistry; Oxidants - pharmacology; Oxidation-Reduction - drug effects; Peracids
• ISSN: 0003-9861; 1096-0384
• DOI: 10.1016/j.abb.2009.10.014

Our previous rapid-scanning stopped-flow studies of the reaction of substrate-free cytochrome P450cam with peracids [T. Spolitak, J.H. Dawson, D.P. Ballou, J. Biol. Chem. 280 (2005) 20300–20309; J. Inorg. Biochem. 100 (2006) 2034–2044; J. Biol. Inorg. Chem. 13 (2008) 599–611] spectrally characterized compound I (ferryl iron plus a porphyrin π-cation radical (Fe IV O/Por + )), Cpd ES, and Cpd II (Fe IV O/Tyr or Fe IV O). We now report that reactions of CYP153A6 with peracids yield all these intermediates, with kinetic profiles allowing better resolution of all forms at pH 8.0 compared to similar reactions with WT P450cam. Properties of the reactions of these higher oxidation state intermediates were determined in double-mixing experiments in which intermediates are pre-formed and ascorbate is then added. Reactions of heptane-bound CYP153A6 (pH 7.4) with mCPBA resulted in conversion of P450 to the low-spin ferric form, presumably as heptanol was formed, suggesting that CYP 153A6 is a potential biocatalyst that can use peracids with no added NAD(P)H or reducing systems for bioremediation and other industrial applications.